AI-generated summary
In rat and cultured retinal cell models of diabetes, the authors report that daily 670-nm light treatment was associated with less retinal ganglion cell death, better electroretinogram responses, reduced oxidative stress and reduced inflammation. The authors describe these as early, preclinical findings in animals and cells, not human results.
- Who or what was studied
- Streptozotocin-induced diabetic rats and cultured retinal cells
- Wavelengths
- 670 nm
- Limits stated in the abstract
- The study used animal and cultured cell models, so the findings may not apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on iovs.arvojournals.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oxidative stress, Retina, Near-infrared, Inflammation, Biomarker. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.